Ramipril
Generic Name: Ramipril
Uses & Medical Indications
Treatment of hypertension, heart failure post-MI, reduction in risk of MI/stroke
Hypertension, Heart Failure, Cardiovascular Risk Reduction
Work Mechanism & Pharmacology
Patient Overview of Work Mechanism
Ramipril relaxes tight blood vessels and supports regular cardiac pumping, keeping blood pressure within a healthy range and protecting heart health.
Clinical Mechanism of Action (MoA)
Ramipril lowers elevated blood pressure and relieves myocardial workload by inducing systemic vasodilation, antagonizing adrenergic sympathetic tone, or inhibiting the renin-angiotensin-aldosterone axis.
Dosage & Administration Guidelines
2.5-5 mg once daily, titrate to 10 mg/day
Not generally recommended
Start at 1.25-2.5 mg daily
20 mg/day (hypertension)
Start at 1.25 mg if CrCl < 40 mL/min
No adjustment necessary
Side Effects & Safety Warnings
Dry cough, headache, dizziness, fatigue
Angioedema, hyperkalemia, symptomatic hypotension, renal failure
History of angioedema, concurrent use with aliskiren in diabetes
Fetal toxicity; discontinue as soon as pregnancy is detected
Interactions (Drugs, Food & Alcohol)
Potassium-sparing diuretics, NSAIDs, lithium, ARBs
N/A
Increases hypotensive effects
Pregnancy & Breastfeeding Safety
Boxed warning: fetal toxicity
Not recommended
Patient Counseling & Practical Advice
Report swelling of face/throat or persistent dry cough.
Take as soon as remembered. Skip if near next dose.
Blood pressure, serum potassium, renal function
Related Medicines in ACE Inhibitors
When to Seek Urgent Medical Attention
Seek immediate emergency medical care (call emergency services or proceed to the nearest emergency department) if you experience signs of a life-threatening allergic reaction (anaphylaxis: facial, lip, tongue, or throat swelling causing airway obstruction), severe cutaneous blistering with skin peeling, sudden intense chest pain, or symptoms of overdose.
Content for Ramipril was synthesized from standardized public health monographs, official pharmacopoeias, and health authorities:
- Central Drugs Standard Control Organization (CDSCO) — National List of Essential Medicines
- World Health Organization (WHO) — Model List of Essential Medicines
- Indian Pharmacopoeia Commission (IPC) — Indian Pharmacopoeia Drug Monographs
- National Health Service (NHS) — Medicines A to Z Clinical Guidelines
The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.